We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $141M
1-Year Est. Return 190.82%
This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+190.82%
3 Year Est. Return
+375.7%
5 Year Est. Return
+81.85%
10 Year Est. Return
+4,735.29%
AUM
$95M
AUM Growth
-$36.3M
Cap. Flow
-$17.3M
Cap. Flow %
-18.23%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
BOLD
Audentes Therapeutics, Inc
BOLD
+$16.5M
2
OPGN
OpGen, Inc
OPGN
+$791K

Sector Composition

Rank Sector Weight
1 Healthcare 76.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOLD
1
DELISTED
Audentes Therapeutics, Inc
BOLD
$37.6M 39.61%
1,204,615
-602,217
-33% -$16.5M
AKAO
2
DELISTED
Achaogen Inc
AKAO
$13.8M 14.48%
1,281,152
– –
OCUL icon
3
Ocular Therapeutix
OCUL
$1.83B
$9.86M 10.37%
2,215,384
– –
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
$9.65M 10.15%
1,048,601
– –
IMDZ
5
DELISTED
Immune Design Corp.
IMDZ
$8.61M 9.06%
2,208,210
– –
VANI icon
6
Vivani Medical
VANI
$114M
$8.58M 9.03%
187,207
– –
CLVS
7
DELISTED
Clovis Oncology, Inc.
CLVS
$6.93M 7.29%
101,855
– –
OPGN
8
DELISTED
OpGen, Inc
OPGN
– –
-26
Closed -$791K

Similar funds

POIA
Pin Oak Investment Advisors Houston, Texas $141M AUM 20.83% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
TM
TFJ Management Somerville, Massachusetts $141M AUM 9.28% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
RB
Renasant Bank Tupelo, Mississippi $141M AUM 16.9% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
CFGW
Chancellor Financial Group WB Wilkes-Barre, Pennsylvania $141M AUM 23.22% 1-Year Est. Return

Versant Venture Management's Q4 2017 Portfolio in Review

As of Q4 2017, Versant Venture Management held 8 positions worth $95M, down 28% from $131M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Versant Venture Management withdrew a net $17.3M in Q4 2017, closing 1 position and reducing 1 holding. Its most notable exit was OpGen, Inc, an estimated $791K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 66% a quarter earlier.

  • Versant Venture Management's biggest Q4 2017 reduction was Audentes Therapeutics, Inc, cutting an estimated $16.5M.
  • Versant Venture Management fully exited OpGen, Inc in Q4 2017, selling an estimated $791K.
  • Versant Venture Management's ten largest holdings make up 100% of its $95M portfolio in Q4 2017.
  • Versant Venture Management opened 0 new positions and closed 1 in Q4 2017.
  • Versant Venture Management's portfolio value fell 28% quarter-over-quarter to $95M.

Based on Versant Venture Management's 13F filing for Q4 2017, filed 25 Jan 2018.